SCHEMBL23129154

SCHEMBL23129154

c1ccc(-c2nc(-n3c4ccc5ccccc5c4c4c5c6ccccc6c6ccccc6c5ccc43)nc3c2ccc2ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
L3MBTL1 Q9Y468 4/20 0.35
LMNA P02545 2/20 0.35
HPRT1 P00492 1/20 0.33
MAOA P21397 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TLR8 Q9NR97 1/20 0.32
MAPK1 P28482 1/20 0.32
RECQL P46063 1/20 0.32
MMP14 P50281 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ADORA2A P29274 1/20 0.31
NUDT1 P36639 1/20 0.31
CYP1A2 P05177 3/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23129104 0.97 ALDH1A1 (0.35) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL24596657 0.94 ALDH1A1 (0.38) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL23129391 0.90 ALDH1A1 (0.34) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL23983836 0.90 ALDH1A1 (0.35) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL18026430 0.90 MAPT (0.37) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL22211857 0.89 ALDH1A1 (0.35) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL23983627 0.89 MAPK8 (0.34) ALDH1A1MAPTKDM4EL3MBTL1LMNA
SCHEMBL23129419 0.88 ALDH1A1 (0.33) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL26973632 0.88 ALDH1A1 (0.34) ALDH1A1HPGDMAPTKDM4ENPSR1
SCHEMBL22133345 0.86 L3MBTL1 (0.40) ALDH1A1HPGDMAPTKDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same LG CHEM, LTD. (KR) 2024-01-02 US disclosed
US-20210340159-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG CHEM, LTD. (KR) 2021-11-04 US disclosed
EP-3795569-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340159-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME NR4A1, CYP1A1, ARNT ALDH1A1 228/4885HPGD 2436/4885MAPT 3330/4885
US-11858947-B2 Heterocyclic compound and organic light emitting device including the same NR4A1, CYP1A1, ARNT ALDH1A1 228/4885HPGD 2436/4885MAPT 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.